The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4615-1871-6_17PMID 8540312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between the prevalence of gastritis and gastric cancer in Japan

  2004cited by this paper
• Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer

  1993cited by this paper
• Correlation between Atrophic Gastritis Prevalence and Gastric Cancer Mortality among Middle-aged Men in 5 Areas in Japan

  1993cited by this paper
• The Significance of Low Serum Pepsinogen Levels to Detect Stomach Cancer Associated with Extensive Chronic Gastritis in Japanese Subjects

  1989cited by this paper
• Serum pepsinogens as a screening test of extensive chronic gastritis

  1987cited by this paper
• Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.

  1982cited by this paper

• Comparison of Gastric Cancer Risk Classifications Using Conventional and New Pepsinogen Criteria

  2023cites this paper
• A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?

  2023cites this paper
• Diagnostic performance of the normal range of gastrin calculated using strict criteria based on a combination of serum markers and pathological evaluation for detecting gastritis: a retrospective study

  2023cites this paper
• Gastric cancer detection using the serum pepsinogen test method

  2021cites this paper
• Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers

  2020cites this paper
• GWAS analysis reveals a significant contribution of PSCA to the risk of Heliobacter pylori-induced gastric atrophy.

  2019cites this paper
• Immunohistochemical Analysis of LGR5 and TROY Expression in Gastric Carcinogenesis Demonstrates an Inverse Trend

  2019cites this paper
• Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen

  2018cites this paper
• Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study

  2018cites this paper
• Premalignant Gastric Lesions in Patients Included in National Colorectal Cancer Screening

  2017cites this paper
• EARLY DETECTION OF GASTRIC CARCINOMA BY ADVANCE ENDOSCOPIC PROCEDURE: AN UPDATE

  2017cites this paper
• Actual Status of Involvement of Helicobacter pylori Infection That Developed Gastric Cancer from Group A of ABC (D) Stratification - Study of Early Gastric Cancer Cases That Underwent Endoscopic Submucosal Dissection

  2016cites this paper
• Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method

  2016cites this paper
• Advanced endoscopic imaging for early gastric cancer.

  2015cites this paper
• Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy

  2015cites this paper
• Influence of Prostate Stem Cell Antigen Gene Polymorphisms on Susceptibility to Helicobacter pylori‐associated Diseases: A Case‐control Study

  2015cites this paper
• Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and after H. pylori Eradication

  2014cites this paper
• False Sero-Negative Results for Helicobacter Pylori Infection Indicate Increased Risk of Severe Atrophic Gastritis in Japanese Patients

  2014cites this paper
• Development of gastric cancer and its prevention.

  2014cites this paper
• Chapter 7 – Gastricsin

  2013cites this paper
• Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker

  2013cites this paper
• A survey and evaluation of population-based screening for gastric cancer

  2013cites this paper
• Chapter 3 – Pepsin A

  2013cites this paper
• Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?

  2013cites this paper
• Structure and function studies on enzymes with a catalytic carboxyl group(s): from ribonuclease T1 to carboxyl peptidases

  2013cites this paper
• Changing Trends of Serum Pepsinogen I/II Ratio in Asymptomatic Subjects

  2012cites this paper
• Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study

  2012cites this paper
• Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”

  2011cites this paper
• Analysis of ABC (D) stratification for screening patients with gastric cancer.

  2011cites this paper
• The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk

  2011cites this paper
• Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.

  2011cites this paper
• Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis

  2010cites this paper
• Predictive Power of Serum Pepsinogen Tests for the Development of Gastric Cancer in Comparison to the Histologic Risk Index

  2010cites this paper
• Strategy for Eliminating Gastric Cancer in Japan

  2010cites this paper
• Cautious comparison between East and West is necessary in terms of the serum pepsinogen test

  2009cites this paper
• LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION

  2009cites this paper
• Comparison of the Validity of Three Biomarkers for Gastric Cancer Screening: Carcinoembryonic Antigen, Pepsinogens, and High Sensitive C-reactive Protein

  2009cites this paper
• Using serum pepsinogens wisely in a clinical practice

  2007cites this paper
• Helicobacter pylori Gastritis, the Unifying Concept for Gastric Diseases

  2007cites this paper
• ENDOSCOPIC STOMACH CANCER SCREENING BASED ON THE HIGH RISK STRATEGY

  2007cites this paper
• Early Gastric Cancer: Diagnosis and Less Invasive Treatments

  2006cites this paper
• Acid-suppressive effects of rabeprazole: comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers.

  2006cites this paper
• Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

  2005cites this paper
• Differences in Clinical Characteristics between Patients with Endoscopy-Negative Reflux Disease and Erosive Esophagitis in Japan

  2005cites this paper
• 3 – Pepsin A

  2004cites this paper
• Prevalence of symptomatic gastro‐oesophageal reflux disease in Japanese patients with peptic ulcer disease after eradication of Helicobacter pylori infection

  2004cites this paper
• Broccoli consumption and chronic atrophic gastritis among Japanese males: an epidemiological investigation.

  2004cites this paper
• Usefulness of Gastric Cancer Screening Using the Serum Pepsinogen Test Method

  2003cites this paper
• Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

  2003cites this paper
• The role of pepsinogen assays as surrogate markers of gastritis dynamics in population studies

  2003cites this paper
• Pepsinogens and Pepsins

  2002cites this paper
• Gastric cancer screening using the serum pepsinogen test method

  2002cites this paper
• Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori.

  2001cites this paper
• Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects

  2001cites this paper
• Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle.

  2000cites this paper
• Helicobacter pylori infection and atrophic gastritis: a nested case-control study in a rural town in Japan.

  1999cites this paper
• Helicobacter pylori Infection and Atrophic Gastritis (A Nested Case-Control Study in a Rural Town in Japan)

  1999cites this paper
• Früherkennungsmaßnahmen in der Onkologie

  1998cites this paper